Turning Pennies into dollars: (OTCBB: GRMU), (OTCBB: ACTC), (Pink Sheets: SMKG), (OTCBB: MAUG).
Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://grmu.realpennies.com
April 4, 2008-- GREM USA (OTCBB: GRMU) ("GREM," "the Company"), an emerging leader in the design and manufacturing of custom hand-crafted and electric guitars, today announced that on April 1, 2008, GREM management hosted Premier Guitar Magazine ("Premier") representatives at its Fort Wayne, Indiana production facility in an enthusiastic and overwhelmingly positive initial meeting to discuss the Company's line of guitars, production methods, and the Company vision. The Company is pleased to note that Premier staff, having first-hand familiarity of the Company's designs and production capability, has asked to spend an additional day at the GREM facility to expand their future feature story on the Company in Premier's popular online and print magazine.
President of GREM USA, Edward Miers, commented, "These are people who have a true passion for music. They live and breathe music. We know they've reviewed and worked with hundreds of other instruments over the years, and we're elated they've taken the time to evaluate our guitars. As a small company, we've worked very hard to achieve the kind of quality we're proud to put our name on, and we're humbled by the praise we've received from Premier thus far."
Brett Petrusek of Premier Guitar Magazine added, "We recognize the quality and effort inherent in the build and performance of GREM guitars, and we're always excited to watch the evolution of the instrument and the industry. We've always supported independent and custom manufacturers who produce finely crafted instruments of their choice. We're intrigued by GREM's entry into producing high-end guitars, and believe they're making a serious effort to be a contender in this space."
The Company anticipates that the industry exposure generated through Premier Guitar should help broadly increase the Company's brand awareness and will be a valuable resource in solidifying GREM's reputation for producing some of the most coveted guitars available on the market today.
About Premier Guitar
Premier Guitar is a monthly publication that is dedicated to the "relentless pursuit of tone" and is edited for serious and accomplished players. The magazine provides gearheads with the resources to help them evolve into better artists and, ultimately, to develop and improve their tone. The magazine, published by Gearhead Communications, is based in Cedar Rapids and Fort Dodge, Iowa. The Company's online portal, http://www.premierguitar.com serves its online visitors that read, and in some cases, print that month's entire issue of Premier Guitar via its unique page turning software.
About GREM USA
GREM USA is a publicly traded company focusing on design and manufacturing of custom hand-crafted and electric guitars. For more information, visit our website at http://gremusa.com/.
For more info: http://actc.realpennies.com
April 4, 2008-- Advanced Cell Technology, Inc. (OTCBB: ACTC) reported Friday on a large-scale differentiation process that has generated panels of differentiating human progenitor cell lines from human embryonic stem cells (hESCs). The research will be published in the April issue of Regenerative Medicine (Vol. 3(3) e-pub ahead of print) and will be freely available at www.futuremedicine.com/loi/rme.
Since the first isolation of hESCs, scientists and industry alike have been working to harness the power of these cells for the purpose of restoring and regenerating body systems that have been damaged by disease or injury
One of the hurdles has been a commercially viable means for the expansion of sufficient numbers of the cell types needed for tissue regeneration. With the publication of work entitled "The ACTCellerate Initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives," ACT scientists have solved some of these problems. The paper describes a system that was established to isolate and clonally expand tissue specific precursors that heretofore could only be isolated from aborted human fetal tissue.
Dr Chris Mason (UCL), Associate Editor of Regenerative Medicine said, "This is an enormously exciting development for the regen sector. The research reported... represents a quantum leap forward in embryonics, the mapping and characterization of the cells of early human development. Without any doubt, the ACTCellerate technology will greatly hasten the translation of human embryonic stem cell-based therapies into safe and effective products for routine clinical practice."
The benefits of the ACTCellerate technology transcend therapeutics and extend as well into revolutionary applications for drug discovery, drug toxicity testing, and cancer research. This advance holds great promise for future research and may one day lead to many new cell-based therapies in the emerging field of regenerative medicine.
Another important finding in this publication is that these normal embryonic progenitor cell types show the expression of certain genes (such as oncofetal markers) often associated in the literature with malignant cancer. However, when these progenitor cells were injected into supportive mice, no malignant tumors could be observed. This indicates that expression of such genes is a function of these cells' normal primitive stage of differentiation and not linked to any disease potential.
William M. Caldwell IV, Chairman and CEO of Advanced Cell Technology, Inc., stated, "We are greatly indebted to Mike West for his insight in initiating this program during his tenure with ACT and to the entire ACT scientific team for their perseverance in bringing this groundbreaking research to the conclusions described in this publication. ACT has taken great strides in identifying both clinical applications for this approach as well as for the ACTCellerate cell line library for drug target discovery, assay development, and direct therapeutics development across a wide spectrum of clinical indications. We are now in a position to offer our refined technology and know-how to potential partners and licensees."
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts.
For more information, visit www.advancedcell.com
For more info: http://smkg.realpennies.com
April 4, 2008-- As Stated by SmartCard Marketing Systems Inc. (Pink Sheets: SMKG) "We are excited by the results of the initial roll out and have wide user acceptance with KIYSS.com merchants and customers using the Velocitymoney.com online virtual wallet and Pin Debit services a unique offering to change the way internet funds are transferred securely worldwide for money remittance and online purchasing.
In the next month the plan is to increase all access to over 6000 customers and commence signing up merchants for Velocitymoney.com that want to accept fund transfers from customers with accounts and also anticipate that big retailers with online sites will also signup. This is the first sizeable group of this magnitude to join Velocitymoney.com to create a more significant and secure environment for merchants and customers that will become the new Industry Paradigm for the online Money Service segment competing with the existing leaders of the industry such as Paypal.com and traditional Banks.
Management of SmartCard anticipates that monthly fee's generated from transactions based on existing business with KIYSS.com "per user" is 4 to 7 transactions a month with about $20k to $35k monthly in fee's and this does not include prepaid card user transactions which can be as much as double those transactions monthly."
Velocitymoney.com
SmartCard Marketing Systems Inc management is continuously informing financial aggregators worldwide on the benefits of card secure transactions with Pin Debit functionality for Money Service businesses online and prepaid card services as a fundamental choice for online charge cards proving Patriot Act compliancy.
For more info: http://maug.realpennies.com
April 4, 2008-- Maui General Store, Inc. (OTCBB:MAUG) today announced that it is preparing to finalize a merger expected in April of this year.
Richard Miller, Maui President/CEO, commented: "We feel we have found a company that has a solid business along with great management, and will give the shareholders good value for their investment. Even though it has taken longer than expected, we feel it was worth the wait and necessary to do the due diligence necessary to find the right company that deserves to be listed as a publicly traded company and can grow exponentially. We expect to disclose the identity of our merger partner shortly."
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
Sponsored by: http://www.isthemarketopen.com
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
